bpc 157 drug 157: is this a supplement I should be taking to improve my healing? The Hidden Risks of BPC‑157:

In a study published in the journal Neurobiology of Disease, researchers demonstrated that Dihexa treatment significantly improved functional recovery and promoted axonal regeneration in rats with spinal cord injury

These findings are echoed in other studies showing that DSIP improves sleep structure and reduces sleep onset time in chronic insomnia

Clinical research Research published in the Journal of Pharmacology and Experimental Therapeutics (McCoy et al., 2013) evaluated metabolically stabilized angiotensin IV analogs, including Dihexa, as pro-cognitive and anti-dementia agents, demonstrating meaningful cognitive improvements in animal models

Why it was included in the FDA ban The agency cited a lack of human trials and the risk for immune reactions and peptide impurities with injectable Thymosin Beta 4

The disconnect between short plasma half-life and prolonged therapeutic effects observed in many studies supports tissue-level mechanisms extending beyond circulating peptide concentrations

Kristensen M (2024) Insulin-inspired peptides may open new pathways to treat Alzheimers disease